As of 2026-04-01, the Relative Valuation of Ibere Pharmaceuticals (IBER) is 5.83 USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.18 USD, the upside of Ibere Pharmaceuticals based on Relative Valuation is -42.7%.
The range of the Relative Valuation is 1.85 - 10.66 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.0x - 29.7x | 26.4x |
| Forward P/E multiples | 20.2x - 25.8x | 24.0x |
| Fair Price | 1.85 - 10.66 | 5.83 |
| Upside | -81.9% - 4.7% | -42.7% |
| Date | P/E |